{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T04:28:13Z","timestamp":1794198493790,"version":"4.8.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81801044"],"award-info":[{"award-number":["81801044"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.bbi.2025.04.034","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T11:08:51Z","timestamp":1745233731000},"page":"400-415","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Blockage of CCL3 with neutralizing antibody reduces neuroinflammation and reverses Alzheimer disease phenotypes"],"prefix":"10.1016","volume":"128","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2982-9010","authenticated-orcid":false,"given":"Chao","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianhao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yane","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanchang","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengge","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bbi.2025.04.034_b0005","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00401-024-02790-2","article-title":"Inflammatory aspects of Alzheimer's disease","volume":"148","author":"Botella Lucena","year":"2024","journal-title":"Acta Neuropathol."},{"issue":"5","key":"10.1016\/j.bbi.2025.04.034_b0010","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3109\/00207454.2013.833510","article-title":"Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease","volume":"124","author":"Cai","year":"2014","journal-title":"Int. J. Neurosci."},{"issue":"6","key":"10.1016\/j.bbi.2025.04.034_b0015","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jalz.2016.02.010","article-title":"Neuroinflammation in Alzheimer's disease: Current evidence and future directions","volume":"12","author":"Calsolaro","year":"2016","journal-title":"Alzheimers Dement."},{"issue":"29","key":"10.1016\/j.bbi.2025.04.034_b0020","doi-asserted-by":"crossref","first-page":"24573","DOI":"10.1074\/jbc.M111.333054","article-title":"Nuclear factor-kappaB regulates betaAPP and beta- and gamma-secretases differently at physiological and supraphysiological Abeta concentrations","volume":"287","author":"Chami","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.bbi.2025.04.034_b0025","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1111\/epi.12993","article-title":"A mouse model of Alzheimer's disease displays increased susceptibility to kindling and seizure-associated death","volume":"56","author":"Chan","year":"2015","journal-title":"Epilepsia."},{"issue":"1","key":"10.1016\/j.bbi.2025.04.034_b0030","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1017\/S1461145711000149","article-title":"Increased NF-kappaB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's disease","volume":"15","author":"Chen","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.bbi.2025.04.034_b0035","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3390\/brainsci13040579","article-title":"Pharmacological modulation of the MIP-1 family and their receptors reduces neuropathic pain symptoms and influences morphine analgesia: evidence from a mouse model","volume":"13","author":"Ciechanowska","year":"2023","journal-title":"Brain Sci."},{"issue":"4","key":"10.1016\/j.bbi.2025.04.034_b0040","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s11011-022-00953-2","article-title":"Reactive gliosis in Alzheimer's disease: a crucial role for cognitive impairment and memory loss","volume":"37","author":"De Sousa","year":"2022","journal-title":"Metab. Brain Dis."},{"issue":"5","key":"10.1016\/j.bbi.2025.04.034_b0045","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1128\/IAI.67.5.2590-2601.1999","article-title":"Neutralization of macrophage inflammatory protein 2 (MIP-2) and MIP-1alpha attenuates neutrophil recruitment in the central nervous system during experimental bacterial meningitis","volume":"67","author":"Diab","year":"1999","journal-title":"Infect. Immun."},{"issue":"8","key":"10.1016\/j.bbi.2025.04.034_b0050","doi-asserted-by":"crossref","first-page":"870","DOI":"10.2174\/1567205014666170317113606","article-title":"Impact of cytokines and chemokines on Alzheimer's disease neuropathological hallmarks","volume":"14","author":"Domingues","year":"2017","journal-title":"Curr. Alzheimer Res."},{"issue":"11","key":"10.1016\/j.bbi.2025.04.034_b0055","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2174\/1567205015666180709112327","article-title":"Progressive spatial memory impairment, brain amyloid deposition and changes in serum amyloid levels as a function of age in APPswe\/PS1dE9 mice","volume":"15","author":"Fu","year":"2018","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.bbi.2025.04.034_b0060","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3389\/fneur.2018.00549","article-title":"Roles of microglial and monocyte chemokines and their receptors in regulating Alzheimer's disease-associated amyloid-beta and Tau pathologies","volume":"9","author":"Guedes","year":"2018","journal-title":"Front. Neurol."},{"issue":"8","key":"10.1016\/j.bbi.2025.04.034_b0065","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.biopsych.2020.02.001","article-title":"The beta-secretase BACE1 in Alzheimer's disease","volume":"89","author":"Hampel","year":"2021","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.bbi.2025.04.034_b0070","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer's disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbi.2025.04.034_b0075","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1478-811X-11-68","article-title":"AMP-activated protein kinase activation mediates CCL3-induced cell migration and matrix metalloproteinase-2 expression in human chondrosarcoma","volume":"11","author":"Hsu","year":"2013","journal-title":"Cell Commun. Signal."},{"issue":"4","key":"10.1016\/j.bbi.2025.04.034_b0080","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s11357-016-9929-7","article-title":"Characterization of AD-like phenotype in aged APPSwe\/PS1dE9 mice","volume":"38","author":"Huang","year":"2016","journal-title":"Age (dordr)"},{"issue":"9","key":"10.1016\/j.bbi.2025.04.034_b0085","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S1474-4422(23)00128-X","article-title":"The complex pathway between amyloid beta and cognition: implications for therapy","volume":"22","author":"Jagust","year":"2023","journal-title":"Lancet Neurol."},{"issue":"9","key":"10.1016\/j.bbi.2025.04.034_b0090","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1016\/j.neurobiolaging.2015.05.010","article-title":"Behavioral abnormalities in APPSwe\/PS1dE9 mouse model of AD-like pathology: comparative analysis across multiple behavioral domains","volume":"36","author":"Janus","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbi.2025.04.034_b0095","article-title":"Synaptic basis of Alzheimer's disease: Focus on synaptic amyloid beta","volume":"65","author":"John","year":"2021","journal-title":"P-Tau and Mitochondria. Ageing Res. Rev."},{"issue":"9","key":"10.1016\/j.bbi.2025.04.034_b0100","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.2174\/1871530320666200131110744","article-title":"The role of chemokines in Alzheimer's disease","volume":"20","author":"Jorda","year":"2020","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"issue":"2","key":"10.1016\/j.bbi.2025.04.034_b0105","doi-asserted-by":"crossref","first-page":"453","DOI":"10.7150\/ijbs.26703","article-title":"Changes in chemokines and chemokine receptors expression in a mouse model of Alzheimer's disease","volume":"15","author":"Jorda","year":"2019","journal-title":"Int. J. Biol. Sci."},{"issue":"4","key":"10.1016\/j.bbi.2025.04.034_b0110","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s10787-019-00580-x","article-title":"Activation of microglia and astrocytes: a roadway to neuroinflammation and Alzheimer's disease","volume":"27","author":"Kaur","year":"2019","journal-title":"Inflammopharmacology"},{"issue":"1","key":"10.1016\/j.bbi.2025.04.034_b0115","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s12035-008-8018-z","article-title":"Dendritic spine loss and synaptic alterations in Alzheimer's disease","volume":"37","author":"Knobloch","year":"2008","journal-title":"Mol. Neurobiol."},{"issue":"11","key":"10.1016\/j.bbi.2025.04.034_b0120","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1002\/alz.12610","article-title":"Role of chronic neuroinflammation in neuroplasticity and cognitive function: A hypothesis","volume":"18","author":"Lecca","year":"2022","journal-title":"Alzheimers Dement."},{"issue":"6","key":"10.1016\/j.bbi.2025.04.034_b0125","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/jnc.15007","article-title":"A mechanistic hypothesis for the impairment of synaptic plasticity by soluble Abeta oligomers from Alzheimer's brain","volume":"154","author":"Li","year":"2020","journal-title":"J. Neurochem."},{"issue":"11","key":"10.1016\/j.bbi.2025.04.034_b0130","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.2174\/1567205013666160703174254","article-title":"Elevations in the levels of NF-kappaB and inflammatory chemotactic factors in the brains with alzheimer's disease - one mechanism may involve alpha3 nicotinic acetylcholine receptor","volume":"13","author":"Liao","year":"2016","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.bbi.2025.04.034_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115149","article-title":"Z-Guggulsterone attenuates cognitive defects and decreases neuroinflammation in APPswe\/PS1dE9 mice through inhibiting the TLR4 signaling pathway","volume":"202","author":"Liu","year":"2022","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbi.2025.04.034_b0140","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/glia.1072","article-title":"Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitro","volume":"35","author":"Lue","year":"2001","journal-title":"Glia"},{"issue":"4","key":"10.1016\/j.bbi.2025.04.034_b0145","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.3390\/molecules27041210","article-title":"Amyloidosis in Alzheimer's disease: pathogeny, etiology, and related therapeutic directions","volume":"27","author":"Ma","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bbi.2025.04.034_b0150","doi-asserted-by":"crossref","first-page":"15862","DOI":"10.1038\/srep15862","article-title":"The Chemokine MIP-1alpha\/CCL3 impairs mouse hippocampal synaptic transmission, plasticity and memory","volume":"5","author":"Marciniak","year":"2015","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bbi.2025.04.034_b0155","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/acel.12522","article-title":"Distinct inflammatory phenotypes of microglia and monocyte-derived macrophages in Alzheimer's disease models: effects of aging and amyloid pathology","volume":"16","author":"Martin","year":"2017","journal-title":"Aging Cell"},{"issue":"11","key":"10.1016\/j.bbi.2025.04.034_b0160","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1523\/JNEUROSCI.5215-08.2009","article-title":"Amyloid beta-induced neuronal hyperexcitability triggers progressive epilepsy","volume":"29","author":"Minkeviciene","year":"2009","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.bbi.2025.04.034_b0165","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jalz.2019.03.007","article-title":"Inflammatory biomarkers in Alzheimer's disease plasma","volume":"15","author":"Morgan","year":"2019","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.bbi.2025.04.034_b0170","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s12974-018-1313-3","article-title":"Inflammation: the link between comorbidities, genetics, and Alzheimer's disease","volume":"15","author":"Newcombe","year":"2018","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.bbi.2025.04.034_b0175","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1006\/mcbr.2000.0247","article-title":"MIP-1alpha induces binding of nuclear factors to the kappaB DNA element in human B cells","volume":"4","author":"Omoike","year":"2000","journal-title":"Mol. Cell Biol. Res. Commun."},{"issue":"1","key":"10.1016\/j.bbi.2025.04.034_b0180","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s12017-009-8091-0","article-title":"Alzheimer's disease amyloid beta-protein and synaptic function","volume":"12","author":"Ondrejcak","year":"2010","journal-title":"Neuromolecular Med."},{"key":"10.1016\/j.bbi.2025.04.034_b0185","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.3389\/fimmu.2019.02231","article-title":"Mimicry of central-peripheral immunity in alzheimer's disease and discovery of neurodegenerative roles in neutrophil","volume":"10","author":"Park","year":"2019","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.bbi.2025.04.034_b0190","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.2353\/ajpath.2009.081113","article-title":"Role of the macrophage inflammatory protein-1alpha\/CC chemokine receptor 5 signaling pathway in the neuroinflammatory response and cognitive deficits induced by beta-amyloid peptide","volume":"175","author":"Passos","year":"2009","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.bbi.2025.04.034_b0195","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.2174\/1570159X19666211201094031","article-title":"BACE1: A key regulator in Alzheimer's disease progression and current development of its inhibitors","volume":"20","author":"Patel","year":"2022","journal-title":"Curr. Neuropharmacol."},{"issue":"1","key":"10.1016\/j.bbi.2025.04.034_b0200","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/s12974-020-02037-3","article-title":"CCL3 contributes to secondary damage after spinal cord injury","volume":"17","author":"Pelisch","year":"2020","journal-title":"J. Neuroinflammation"},{"issue":"7","key":"10.1016\/j.bbi.2025.04.034_b0205","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1038\/s41380-022-01565-z","article-title":"The synapse as a treatment avenue for Alzheimer's Disease","volume":"27","author":"Peng","year":"2022","journal-title":"Mol. Psychiatry"},{"issue":"4","key":"10.1016\/j.bbi.2025.04.034_b0210","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMra0909142","article-title":"Alzheimer's disease","volume":"362","author":"Querfurth","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.bbi.2025.04.034_b0215","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s11064-012-0708-2","article-title":"Neuroinflammation and synaptic loss","volume":"37","author":"Rao","year":"2012","journal-title":"Neurochem. Res."},{"issue":"27","key":"10.1016\/j.bbi.2025.04.034_b0220","doi-asserted-by":"crossref","first-page":"5161","DOI":"10.1523\/JNEUROSCI.2501-19.2020","article-title":"Effect of abeta oligomers on neuronal APP triggers a vicious cycle leading to the propagation of synaptic plasticity alterations to healthy neurons","volume":"40","author":"Rolland","year":"2020","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.bbi.2025.04.034_b0225","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.pneurobio.2006.06.001","article-title":"Transcriptional and translational regulation of BACE1 expression\u2013implications for Alzheimer's disease","volume":"79","author":"Rossner","year":"2006","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbi.2025.04.034_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcn.2020.103551","article-title":"P38K and JNK pathways are induced by amyloid-beta in astrocyte: Implication of MAPK pathways in astrogliosis in Alzheimer's disease","volume":"108","author":"Saha","year":"2020","journal-title":"Mol. Cell. Neurosci."},{"issue":"1","key":"10.1016\/j.bbi.2025.04.034_b0235","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12868-019-0496-6","article-title":"Amyloid-beta plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer's disease","volume":"20","author":"Sakakibara","year":"2019","journal-title":"BMC Neurosci."},{"issue":"3","key":"10.1016\/j.bbi.2025.04.034_b0240","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/imm.13102","article-title":"The role of CCR1 and therapeutic effects of anti-CCL3 antibody in herpes simplex virus-induced Behcet's disease mouse model","volume":"158","author":"Sayeed","year":"2019","journal-title":"Immunology"},{"issue":"10284","key":"10.1016\/j.bbi.2025.04.034_b0245","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer's disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.bbi.2025.04.034_b0250","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1080\/00207454.2016.1212854","article-title":"Neuroinflammation pathways: a general review","volume":"127","author":"Shabab","year":"2017","journal-title":"Int. J. Neurosci."},{"issue":"4","key":"10.1016\/j.bbi.2025.04.034_b0255","doi-asserted-by":"crossref","first-page":"708","DOI":"10.4103\/1673-5374.353484","article-title":"Targeting neuroinflammation in Alzheimer's disease: from mechanisms to clinical applications","volume":"18","author":"Si","year":"2023","journal-title":"Neural. Regen. Res."},{"key":"10.1016\/j.bbi.2025.04.034_b0260","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.neubiorev.2014.02.001","article-title":"Chemokines and chemokine receptors in mood disorders, schizophrenia, and cognitive impairment: a systematic review of biomarker studies","volume":"42","author":"Stuart","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"1","key":"10.1016\/j.bbi.2025.04.034_b0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10753-022-01721-1","article-title":"Neuroinflammation in Alzheimer's disease: current progress in molecular signaling and therapeutics","volume":"46","author":"Thakur","year":"2023","journal-title":"Inflammation"},{"issue":"6","key":"10.1016\/j.bbi.2025.04.034_b0270","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1111\/j.1471-4159.2005.02986.x","article-title":"Specific induction of macrophage inflammatory protein 1-alpha in glial cells of Sandhoff disease model mice associated with accumulation of N-acetylhexosaminyl glycoconjugates","volume":"92","author":"Tsuji","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbi.2025.04.034_b0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101622","article-title":"Glial cells in Alzheimer's disease: From neuropathological changes to therapeutic implications","volume":"78","author":"Uddin","year":"2022","journal-title":"Ageing Res. Rev."},{"issue":"2","key":"10.1016\/j.bbi.2025.04.034_b0280","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00401-015-1386-3","article-title":"Amyloid beta oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis","volume":"129","author":"Viola","year":"2015","journal-title":"Acta Neuropathol."},{"issue":"6","key":"10.1016\/j.bbi.2025.04.034_b0285","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0197-4580(01)00306-2","article-title":"Gene expression profiling of amyloid beta peptide-stimulated human post-mortem brain microglia","volume":"22","author":"Walker","year":"2001","journal-title":"Neurobiol. Aging"},{"issue":"9","key":"10.1016\/j.bbi.2025.04.034_b0290","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200785","article-title":"Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer's disease model","volume":"217","author":"Wang","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbi.2025.04.034_b0295","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.freeradbiomed.2020.02.022","article-title":"Acetyl-11-keto-beta-boswellic acid ameliorates cognitive deficits and reduces amyloid-beta levels in APPswe\/PS1dE9 mice through antioxidant and anti-inflammatory pathways","volume":"150","author":"Wei","year":"2020","journal-title":"Free Radic. Biol. Med."},{"issue":"9","key":"10.1016\/j.bbi.2025.04.034_b0300","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1007\/s12031-022-02047-1","article-title":"Role of chemokines in the development and progression of Alzheimer's disease","volume":"72","author":"Wojcieszak","year":"2022","journal-title":"J. Mol. Neurosci."},{"issue":"22","key":"10.1016\/j.bbi.2025.04.034_b0305","doi-asserted-by":"crossref","first-page":"8425","DOI":"10.1073\/pnas.0400625101","article-title":"Deletion of macrophage-inflammatory protein 1 alpha retards neurodegeneration in Sandhoff disease mice","volume":"101","author":"Wu","year":"2004","journal-title":"Proc. Natl. Acad. Sci. u. s. a."},{"issue":"4","key":"10.1016\/j.bbi.2025.04.034_b0310","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s12264-011-1015-7","article-title":"Biochemical and behavioral characterization of the double transgenic mouse model (APPswe\/PS1dE9) of Alzheimer's disease","volume":"27","author":"Xiong","year":"2011","journal-title":"Neurosci. Bull."},{"issue":"4","key":"10.1016\/j.bbi.2025.04.034_b0315","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nm0498-447","article-title":"Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides","volume":"4","author":"Xu","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.bbi.2025.04.034_b0320","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neurobiolaging.2017.03.021","article-title":"Immune hyperreactivity of Abeta plaque-associated microglia in Alzheimer's disease","volume":"55","author":"Yin","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbi.2025.04.034_b0325","article-title":"Novel therapeutic targeting of CCL3-CCR4 axis mediated apoptotic intesitnal injury in necrotizing enterocolitis","volume":"13","author":"Yuan","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bbi.2025.04.034_b0330","doi-asserted-by":"crossref","first-page":"5790","DOI":"10.1038\/s41598-019-42286-8","article-title":"Neuroinflammation induced by lipopolysaccharide causes cognitive impairment in mice","volume":"9","author":"Zhao","year":"2019","journal-title":"Sci. Rep."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159125001710?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159125001710?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T05:30:48Z","timestamp":1763443848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159125001710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":66,"alternative-id":["S0889159125001710"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2025.04.034","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blockage of CCL3 with neutralizing antibody reduces neuroinflammation and reverses Alzheimer disease phenotypes","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2025.04.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}